Large incidental gastrointestinal stromal tumors in a patient presenting with acutely symptomatic nephrolithiasis: A case report

• Main Authors: Chioma Obinero, BA, Gabriel S. Makar, BS, Jean Sebastien Rowe, MD, Michael S. Makar, BA, Thomas Holdbrook, MD, Alexandre Hageboutros, MD, Francis R. Spitz, MD, FACS, James E. Kovacs, DO
• Format: Article
• Language: English
• Published: Elsevier 2019-05-01
• Series: Radiology Case Reports
• Online Access: http://www.sciencedirect.com/science/article/pii/S1930043318305582
• ISSN: 1930-0433

ABSTRACT: Gastrointestinal stromal tumors (GISTs) are rare mesenchymal neoplasms, representing approximately 1%-2% of all primary gastrointestinal malignancies. Incidental GISTs are often less than 1 cm when discovered and have been reported predominantly in obese patients undergoing surgery for other medical indications. We present the rare case of a large incidental GIST in a nonobese patient with acutely symptomatic nephrolithiasis. Large GISTs may be treated with neoadjuvant imatinib mesylate to reduce tumor size prior to surgery, though some tumors may experience little change in size despite effective treatment. Treatment response for GISTs can be monitored via imaging studies, such as computed tomography or magnetic resonance imaging, but computed tomography is generally preferred over magnetic resonance imaging. Keywords: Large GIST, Choi criteria, RECIST